Market Value1,372,864,097
Total Holdings61
File Date2025-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
SLNO / Soleno Therapeutics, Inc.
CABA / Cabaletta Bio, Inc.
ACHV / Achieve Life Sciences, Inc.
ALKS / Alkermes plc
NXTC / NextCure, Inc.
ATXS / Astria Therapeutics, Inc.
ELVN / Enliven Therapeutics, Inc.
IKNA / Ikena Oncology, Inc.
BDX / Becton, Dickinson and Company
ALNY / Alnylam Pharmaceuticals, Inc.
TMO / Thermo Fisher Scientific Inc.
JAZZ / Jazz Pharmaceuticals plc
BSX / Boston Scientific Corporation
SRPT / Sarepta Therapeutics, Inc.
KURA / Kura Oncology, Inc.
TGTX / TG Therapeutics, Inc.
BIOA / BioAge Labs, Inc.
AXSM / Axsome Therapeutics, Inc. Put
AXSM / Axsome Therapeutics, Inc.
INSM / Insmed Incorporated
IMNM / Immunome, Inc.
SYK / Stryker Corporation
PHVS / Pharvaris N.V.
REPL / Replimune Group, Inc.
COGT / Cogent Biosciences, Inc.
RVMD / Revolution Medicines, Inc.
CATX / Perspective Therapeutics, Inc.
IMTXW / Immatics N.V. - Equity Warrant
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
RYTM / Rhythm Pharmaceuticals, Inc.
EW / Edwards Lifesciences Corporation
YMAB / Y-mAbs Therapeutics, Inc.
ERAS / Erasca, Inc.
ILMN / Illumina, Inc.
JANX / Janux Therapeutics, Inc.
VIR / Vir Biotechnology, Inc.
NARI / Inari Medical, Inc.
ICUI / ICU Medical, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
KROS / Keros Therapeutics, Inc.
EXAS / Exact Sciences Corporation
GH / Guardant Health, Inc.
INCY / Incyte Corporation
ABBV / AbbVie Inc.
DHR / Danaher Corporation
SLNO / Soleno Therapeutics, Inc. Put
IRON / Disc Medicine, Inc.
ESTA / Establishment Labs Holdings Inc.
SVRA / Savara Inc.
NTRA / Natera, Inc.
AVBP / ArriVent BioPharma, Inc.
ANAB / AnaptysBio, Inc.
RNA / Atrium Therapeutics, Inc.
GILD / Gilead Sciences, Inc.
VERA / Vera Therapeutics, Inc.
INBX / Inhibrx Biosciences, Inc.
RAPP / Rapport Therapeutics, Inc.
DXCM / DexCom, Inc.
IDYA / IDEAYA Biosciences, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
NVS / Novartis AG - Depositary Receipt (Common Stock) Put
MRNS / Marinus Pharmaceuticals, Inc.
LUNG / Pulmonx Corporation
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
DYN / Dyne Therapeutics, Inc.
IMTX / Immatics N.V.
PAHC / Phibro Animal Health Corporation
TVTX / Travere Therapeutics, Inc.
ELAN / Elanco Animal Health Incorporated
INZY / Inozyme Pharma, Inc.
AVTR / Avantor, Inc.
AVTE / Aerovate Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc. Call
GMED / Globus Medical, Inc.
BOLT / Bolt Biotherapeutics, Inc.
ISRG / Intuitive Surgical, Inc.
LLY / Eli Lilly and Company